1004 related articles for article (PubMed ID: 18775919)
1. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.
Hajer GR; van Haeften TW; Visseren FL
Eur Heart J; 2008 Dec; 29(24):2959-71. PubMed ID: 18775919
[TBL] [Abstract][Full Text] [Related]
2. White adipose tissue and cardiovascular disease.
Matsuzawa Y
Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):637-47. PubMed ID: 16311222
[TBL] [Abstract][Full Text] [Related]
3. Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue.
Lafontan M; Girard J
Diabetes Metab; 2008 Sep; 34(4 Pt 1):317-27. PubMed ID: 18550411
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995
[TBL] [Abstract][Full Text] [Related]
5. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
6. Adipose tissue dysfunction in obesity.
Blüher M
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
[TBL] [Abstract][Full Text] [Related]
7. Endocrine and signalling role of adipose tissue: new perspectives on fat.
Trayhurn P
Acta Physiol Scand; 2005 Aug; 184(4):285-93. PubMed ID: 16026420
[TBL] [Abstract][Full Text] [Related]
8. Lifestyle modification and endothelial function in obese subjects.
Hamdy O
Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
[TBL] [Abstract][Full Text] [Related]
9. [Fat mass expansion, fatty acids and adipokines: metabolic markers and risk factors for cardiovascular pathologies].
Lafontan M
Ann Pharm Fr; 2013 Jan; 71(1):13-26. PubMed ID: 23348852
[TBL] [Abstract][Full Text] [Related]
10. Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.
Goralski KB; Sinal CJ
Can J Physiol Pharmacol; 2007 Jan; 85(1):113-32. PubMed ID: 17487251
[TBL] [Abstract][Full Text] [Related]
11. Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors.
You T; Yang R; Lyles MF; Gong D; Nicklas BJ
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E741-7. PubMed ID: 15562250
[TBL] [Abstract][Full Text] [Related]
12. The role of fat topology in the risk of disease.
Matsuzawa Y
Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S83-92. PubMed ID: 19136997
[TBL] [Abstract][Full Text] [Related]
13. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.
Skurk T; Hauner H
Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1357-64. PubMed ID: 15356668
[TBL] [Abstract][Full Text] [Related]
14. [Adipose tissue: a multifunctional organ].
Bon GB
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):23S-28S. PubMed ID: 18773748
[TBL] [Abstract][Full Text] [Related]
15. Visceral obesity and the heart.
Mathieu P; Pibarot P; Larose E; Poirier P; Marette A; Després JP
Int J Biochem Cell Biol; 2008; 40(5):821-36. PubMed ID: 18201922
[TBL] [Abstract][Full Text] [Related]
16. The metabolic syndrome: metabolic changes with vascular consequences.
Wassink AM; Olijhoek JK; Visseren FL
Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
[TBL] [Abstract][Full Text] [Related]
17. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease.
Martínez-Clemente M; Clària J; Titos E
Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):347-53. PubMed ID: 21587068
[TBL] [Abstract][Full Text] [Related]
18. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome.
Wajchenberg BL; Giannella-Neto D; da Silva ME; Santos RF
Horm Metab Res; 2002; 34(11-12):616-21. PubMed ID: 12660870
[TBL] [Abstract][Full Text] [Related]
19. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease.
Matsuzawa Y
Nat Clin Pract Cardiovasc Med; 2006 Jan; 3(1):35-42. PubMed ID: 16391616
[TBL] [Abstract][Full Text] [Related]
20. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
Black PH
Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
